Understanding Post-Drug Syndromes

Across different medications and supplements, some individuals report a similar pattern: symptoms emerging or intensifying after stopping a substance, rather than while actively taking it. These experiences are commonly described as a “crash”—a destabilization that can affect sexual function, mood, cognition, stress tolerance, and overall well-being.


The conditions below are community-defined syndromes based on shared symptom patterns and self-reports; mechanisms remain under investigation, and experiences vary widely between individuals.

Post -Drug Syndromes

  • Post-Finasteride Syndrome (PFS) describes persistent symptoms reported after stopping finasteride or dutasteride, medications that inhibit 5-alpha-reductase. Similar symptom patterns have also been reported after discontinuing certain supplements—such as lion’s mane and ashwagandha—that may intersect with androgen or neurosteroid pathways. While these substances differ, communities often group them together because of overlapping symptom profiles and the timing of symptom onset after cessation.

    Related syndromes include Post-Ashwaganda symptoms and Post-Lions Mane symptoms.

  • Post-SSRI Sexual Dysfunction (PSSD) refers to sexual and neuropsychiatric symptoms that persist after discontinuing SSRIs or SNRIs. Regulatory agencies have acknowledged reports of lasting sexual dysfunction following these medications, though prevalence and mechanisms remain uncertain. Some individuals report symptoms beginning during treatment, while others describe a marked worsening or delayed onset after stopping—particularly following rapid discontinuation or medication changes.

  • Post-Accutane Syndrome refers to persistent symptoms reported by some individuals after discontinuing isotretinoin, an oral retinoid used for severe acne. While many tolerate the drug without lasting issues, others describe a delayed onset of symptoms that appear or worsen after stopping. These reports have led to discussion of long-term effects on neurosteroids, androgen signaling, inflammation, and gene regulation, though no single mechanism has been established.

Commonly Reported Side Effects

    • Sexual dysfunction

    • Libido loss

    • Erectile dysfunction

    • Genital numbness, Genital shrinkage

    • Pelvic floor disfunction

    • Psychological / Emotional Disfunction

    • Emotional flattening or loss of pleasure (anhedonia)

    • Can’t feel alcohol buzz or weed buzz

    • Anxiety, panic, or stress intolerance

    • Cognitive impairment or “disconnection”

    • Sleep disturbances and fatigue

    • Depression

    • Suicidal Thoughts

    • Physical Change

    • Gut issues, SIBO, Leaky Gut, Food Sensitivities

    • Muscle loss

    • Skin changes (thinning, flexibility, dryness, rashes)

    • Face changes (sunken, aging)

    • Hair changes (thinning, dry, loss of oily scalp)

    • Vision change, dry eyes

    • Tinnitus

    • Gynecomastia

    • Exercise Intolerance

Post Lions Mane Explained
Melangi Paper PFS & PSSD Relationship
PFS Network Paper
PSSD & PAS Mechanisms
PSSD INFO

Next Steps Buttons Below

Recovery Roadmap
Reported Improvement Anecdotes
Reported Crash Substance Directory
Reported Crash Pattern Overview

Important Context

These syndromes are not formal diagnoses, and there are no approved cures or standardized treatment protocols. The information presented here reflects shared patterns from self-reports, not definitive medical conclusions. Individual experiences vary substantially, and recovery trajectories differ widely.